Marker Therapeutics, Inc. (MRKR)

1.63 +0.16 (+10.88%) USD  |  NASDAQ  |  Feb 24, 16:00
1.58 -0.05 (-3.07%) After-Hours: 07:11
More

Marker Therapeutics Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc --
Neurocrine Biosciences, Inc. Upgrade